Related Experiment Video

Updated: Aug 7, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Metabolic and immunologic derangements in cardiac cachexia: where to from here?

Sabine Strassburg1, Stefan D Anker

  • 1Dept. of Cardiology, Applied Cachexia Research, Charité, Campus Virchow-Klinikum, Berlin, Germany.

Heart Failure Reviews
|July 5, 2006
PubMed

Insights

Cardiac cachexia, severe weight loss in advanced chronic heart failure, predicts mortality. Early intervention targeting metabolic and neurohormonal pathways is crucial to slow its progression and improve patient outcomes.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Pharmacology

Background:

  • Cardiac cachexia is a severe wasting syndrome in advanced chronic heart failure (CHF).
  • It is strongly associated with increased mortality in CHF patients.
  • Current understanding of its complex pathophysiology is evolving.

Purpose of the Study:

  • To review current and emerging therapeutic strategies for cardiac cachexia.
  • To highlight the importance of early intervention in managing this condition.
  • To identify areas for future research in cardiac cachexia treatment.

Main Methods:

  • Review of recent studies on potential therapeutics including beta-blockers, ghrelin, and ghrelin-agonists.
  • Analysis of the impact of interventions like heart transplantation on cardiac cachexia.
  • Examination of the complex interplay of metabolic, neurohormonal, and immune systems in cachexia.

Main Results:

  • Beta-blockers, ghrelin, and ghrelin-agonists show potential in managing cachexia.
  • Heart transplantation may influence cardiac cachexia.
  • Complex pathophysiological interactions promote a vicious cycle of wasting.

Conclusions:

  • Early therapeutic intervention is critical to prevent and slow cardiac cachexia progression.
  • Targeting metabolic, neurohormonal, and immune abnormalities offers therapeutic potential.
  • Further research is essential to elucidate pathways and validate new treatments.

Related Concept Videos

Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...